Balestier
3
28M
2
0.33
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Balestier, startups are often financed by Ben Franklin Technology Partners of Southeastern Pennsylvania. The meaningful sponsors for the fund in investment in the same round are Synergy Ventures, Sofinnova Partners, French sovereign investment bank.
The high activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
We can highlight the next thriving fund investment areas, such as Medical Device, Emergency Medicine. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Cagent Vascular, LimFlow SA. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Follow on index
- 0.33
- Investments by industry
- Medical Device (3)
- Health Care (2)
- Emergency Medicine (2)
- Investments by region
-
- France (2)
- United States (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cagent Vascular | 12 Jul 2018 | Medical Device | Early Stage Venture | 11M | United States, Pennsylvania, Radnor Township |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.